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ABSTRACT 
Objective: Aim of this study is to determine frequency 
of patients with type-2 diabetes mellitus who refuse to 
take insulin therapy 
Design & duration: This is a cross sectional study 
completed in six months duration. 
Setting: Study was conducted in medical out-patient 
door of Bahawal Victoria Hospital Bahawalpur. 
Patients & methods: Patients presenting to out-patient 
door of medical department having type-2 diabetes 
taking oral anti diabetics and having poor glycemic 
control. When these patients were advised to take insulin 
therapy their response was documented on a performa. 
Who refused they were asked about its reason and their 
perspective which was noted down. Consent was taken 
from all cases in study group. Permission was taken from 
ethical committee of the institution. Patients of either sex 
and of any age were included in the study. Confidence 
level. Confidence interval was 95% with 5% margin of 
error. 
Results: Total 200 cases were studied including 62% 
female and 38% male patients. When these patients were 
advised to take insulin therapy, 5.5% agreed while 94.5% 
refused. Main cause of refusal was fear of injection pain 
in 41.3% cases and fear of addiction was in 27% cases. 
Mean age of patients was 40.3±8.5 years.   
Conclusion:  Majority of type-2 diabetic people on oral 
antidiabetics have fear to use insulin therapy. Injection 
site pain or fear of addition are main causes of refusal 
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INTRODUCTION 
Prevalence of type-2 diabetes mellitus has been 
increased much in previous years in Pakistan. 
According to a study there are 6.6 million diabetic 
patients between 20-79 years. When glycemic 
control is poor with oral anti diabetics, insulin 
therapy is necessary. In most of patients oral 
medicines are not sufficient to control blood 
glucose level hence complications develop. 
According to a study conducted in UK newly 
diagnosed type-2 diabetic patients were given 
insulin therapy initially. Increasing incidence of 
diabetes mellitus and meanwhile increasing refusal 
of insulin therapy among people is a big challenge 
for healthcare providers in Pakistan. Insulin therapy 
is much effective but its use is usually delayed in 
our people hence increasing its resistance. A 
similar study conducted in Malaysia reported 
psychological insulin resistance due to fear of pain 
associated with injection and fear of hypoglycemia. 
Mutual decision of healthcare providers and patient 
for starting insulin therapy is necessary. Proper 
counselling of such patients is much required. 
Healthcare provider can help patient in making 
decision by giving them awareness about false 
fears and assuring them of better outcome. 
Encouragement and awareness to the patient is 
much required in our community where most of the 
people are illiterate. 
PATIENTS AND METHODS 
This is a cross sectional study conducted in a 
tertiary care hospital Bahawal Victoria Hospital 
Bahawalpur. Study was initiated in January and 
completed after six months in June 2020. Patients 
presenting to out-patient door of medical 
department having type-2 diabetes taking oral anti 
diabetics and having poor glycemic control. When 
these patients were advised to take insulin therapy 
their response was documented on a performa. 
Who refused they were asked about its reason and 
their perspective which was noted down. Consent 
was taken from all cases in study group. Permission 
was taken from ethical committee of the institution. 
Patients of either sex and of any age were included 
in the study. Confidence level. Confidence interval 
was 95% with 5% margin of error. Inclusion and 
exclusion criteria were followed for sample 
selection. Non probability consecutive sampling 
technique was used.  
RESULTS 
 Total 200 cases were studied including 124(62%) 
female and 76(38%) male patients. When these 
patients were advised to take insulin therapy, 
11(5.5%) agreed while 189(94.5%) refused. Main 
cause of refusal was fear of injection pain in 
78(41.3%) cases and fear of addiction was in 
51(27%) cases. Mean age of patients was 40.3±8.5 
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years. There were 42(22.2%) patients having fear 
of poor quality of life due to insulin therapy, 
6(3.2%) patients were having excuse of lack of 
dispensing facility and 12(6.4%) people were 
having reasons of refusal other than mentioned 
above.   
 
 
(Figure-1) Causes of refusal from insulin therapy  
(Table-1) Age distribution of cases in study 
group 
Age of 
patients 
(years) 
  N     % 
20-30 11 5.5 
31-40 25 12.5 
41-50 19 9.5 
51-60 103 51.5 
>60 42 21 
DISCUSSION 
Diabetes mellitus is a very common disease having 
high prevalence rate all over the world. It is much 
expensive disease having burden of cost on patients 
and healthcare system of any country. Its incidence 
is increasing with the passage of time. In this 
aspect healthcare system invest on prevention, 
diagnosis and management of disease, professional 
training, monitoring of services and pharmaceutical 
care. Healthcare providers noticed that when 
doctors advise diabetic patients to take insulin 
therapy due to their poor glycemic control, 
majority of patients refuse to take it due to poor 
awareness of its benefits.  Prevalence of type-2 
diabetes mellitus has been increased much in 
previous years in Pakistan. According to a study 
there are 6.6 million diabetic patients between 20-
79 years. When glycemic control is poor with oral 
anti diabetics, insulin therapy is necessary. In most 
of patients oral medicines are not sufficient to 
control blood glucose level hence complications 
develop. Total 200 cases were studied including 
124(62%) female and 76(38%) male patients. 
When these patients were advised to take insulin 
therapy, 11(5.5%) agreed while 189(94.5%) 
refused. Main cause of refusal was fear of injection 
pain in 78(41.3%) cases and fear of addiction was 
in 51(27%) cases. According to a study conducted 
in UK newly diagnosed type-2 diabetic patients 
were given insulin therapy initially. This is a cross 
sectional study conducted in a tertiary care hospital 
Bahawal Victoria Hospital Bahawalpur. Study was 
initiated in January and completed after six months 
in June 2020. Patients presenting to out-patient 
door of medical department having type-2 diabetes 
taking oral anti diabetics and having poor glycemic 
control. When these patients were advised to take 
insulin therapy their response was documented on a 
performa. Who refused they were asked about its 
reason and their perspective which was noted 
down. Increasing incidence of diabetes mellitus and 
meanwhile increasing refusal of insulin therapy 
among people is a big challenge for healthcare 
providers in Pakistan. Insulin therapy is much 
effective but its use is usually delayed in our people 
hence increasing its resistance. Insulin needs to be 
stored in a refrigerator with proper temperature, but 
most of our people don’t have this facility due to 
lack of refrigerator or mostly due to lack of 
electricity or frequent power failure.  
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CONCLUSION 
Psychological insulin resistance by our community 
is a major challenge for our healthcare providers. 
Most of our diabetic patients come from rural areas 
and hence have very low awareness about their 
disease and treatment. Most of them are illiterate. 
Majority of type-2 diabetic people on oral 
antidiabetics have fear to use insulin therapy. 
Injection site pain or fear of addition are main 
causes of refusal. 
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